iwCLL Tumor Response Criteria Piloted for Lymphoma Clinical Trials

The Clinical Research Imaging Core (CRIC) and the Radius Lab are piloting a potential new service line for lymphoma clinical trial tumor response assessments using  iwCLL Assessment Criteria.  The iwCLL assessment criteria is unique in that it integrates tumor measurements along with clinical assessments and biomarkers to determine a patient’s overall response to treatment.  CRIC is excited to work with UWCCC Lymphoma disease oriented team and the Radius Core Lab to pilot this service.